Personalized 6-month programme for frailty in older people with bladder or kidney cancer
Tests an exercise and education programme against frailty in older bladder or kidney cancer patients.
Key facts
- Who runs it
- Centre Hospitalier Universitaire de Saint Etienne
- Where
- Saint-Etienne, FranceSee the 2 sites
- Trial code
- Registry title
- Effectiveness of a Personalized 6-month Programme on Frailty in Older Patients Treated for Bladder or Kidney Cancer.
- Status
- Recruiting
- People taking part
- 106 people, planned
- Started
- 3 Dec 2025
- Expected to end
- Mar 2028
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- APA
- Therapeutic education workshops
- DAPAP
- Record updated
- 9 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 65 and older with bladder or kidney cancer who are about to have surgery. It tests a 6-month personalized programme before and after surgery.
- Age
- 65 years and older
- Sex
- All sexes can join
- Disease stage
- Bladder or kidney cancer treated with surgery; surgery must not be done yet
- Earlier treatment
- Surgery must not already be done. People already on a prehabilitation prescription with a private physiotherapist cannot join.
Main reasons for not taking part
- Surgery already done
- Other health problems that make physical activity unsafe, such as heart disease, lung disease or disabling joint disease
- Severe cognitive impairment that prevents understanding the study
- Deprived of liberty or under guardianship
- Already on a prehabilitation prescription with a private physiotherapist
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Diagnosis of bladder or kidney cancer
- Surgical treatment
- No severe cognitive impairment preventing understanding of the protocol
- Affiliated or entitled to a social security scheme
- Having received informed information about the study and having co-signed, with the investigator, a consent to participate in the study
Who cannot take part
- Surgery already done
- Significant co-morbidities that contraindicate physical activity: associated cardiac pathologies, respiratory pathologies, disabling joint pathologies, etc
- Deprived of liberty or under guardianship
- Benefiting from a prehabilitation prescription with a private physiotherapist
Where in France
- CHU Saint-EtienneSaint-Etienne, FranceContact: David HUPIN, MDTaking people
- Hôpital privé de la LoireSaint-Etienne, FranceContact: Emilie FAVIER, MDNot yet recruiting
About the trial
What the trial wants to find out
Bladder and kidney cancers are commonly diagnosed in older adults. Surgery remains the primary treatment modality for patients with kidney or bladder cancer. In older patients, common co-morbidities include fatigue, physical deconditioning characterized by reduced cardiorespiratory fitness and progressing sarcopenia, pain- whether disease- related or treatment-induced- and undernutrition. These factors increased the risk of post-operative complications and exacerbate patient frailty.
Read full original descriptionShow less
The investigators propose a personalized 6-month program both pre- and post-surgery, including adapted physical activity sessions, therapeutic education workshops, and systematic referral to the department's DAPAP program.
The 2 groups in the trial
- Control groupNo study treatment, for comparison
The control group will consist of patients with bladder or kidney cancer receiving standard care, which includes a comprehensive assessment by an oncogeriatrician followed by surgery approximately 4 weeks later. Postoperatively, patients will be transferred to a rehabilitation center (SSR) for recovery, in line with standard clinical practice. As part of the study protocol, control group patients will undergo additional follow-up assessments alongside their usual care. These follow-ups-conducted at baseline, and at 1, 2, 3 months, and at the final endpoint-will mirror those of the intervention group. They will include patients- completed questionnaires and physical assessments conducted by an adapted physical activity teacher.
- Interventional groupTreatment being tested
The interventional group will consist of bladder and kidney cancer patients who will follow a personalized 6-month care pathway in addition to standard care. This pathway includes: * 2 adapted physical activity (APA) sessions per week for 4 weeks prior to surgery * 2 APA sessions/ week for 4 weeks following surgery * Therapeutic education workshops tailored to individual needs, covering topics as physical activity, nutrition, treatments, fatigue, and relaxation * Referral to the department's DAPAP for a 12-week "bridge program", consisting of one APA session per week. The study will be conducted in the oncogeriatrics departments of Saint-Etienne University Hospital and Loire Private Hospital.
Treatment: APA, Therapeutic education workshops, and DAPAP
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effectiveness of a Personalized 6-month Programme on Frailty in Older Patients Treated for Bladder or Kidney Cancer - FRAGECO - Multicenter, Controlled, Randomized Study
- Plain-language title
- Personalized 6-month programme for frailty in older people with bladder or kidney cancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Record updated
- 9 December 2025